The CAR-T Congress USA 2018 is dedicated to the challenges and opportunities of CAR-T therapies in both liquid and solid tumors.
Topics
- Commercialisation, regulation & implementation
- Alternative cell constructs: TCRs, gamma delta T cells, CAR-NK & CAR-Tregs
- Scalability, automation & process development
- Safety, control & the underlying mechanisms of toxicity
- Patient access & strategic considerations
- Target identification & neoantigen discovery
- Investment & partnering workshops
Who should Attend
Attendees from biotech, big pharma, academia and investment.
